Learn About Fibrous Dysplasia

What is the definition of Fibrous Dysplasia?

Fibrous dysplasia is a bone disease that destroys and replaces normal bone with fibrous bone tissue. One or more bones can be affected.

What are the alternative names for Fibrous Dysplasia?

Inflammatory fibrous hyperplasia; Idiopathic fibrous hyperplasia; McCune-Albright syndrome

What are the causes of Fibrous Dysplasia?

Fibrous dysplasia usually occurs in childhood. Most people have symptoms by the time they are 30 years old. The disease occurs more often in females.

Fibrous dysplasia is linked to a problem with genes (gene mutation) that control bone-producing cells. The mutation occurs when a baby is developing in the womb. The condition is not passed from parent to child.

What are the symptoms of Fibrous Dysplasia?

Symptoms may include any of the following:

  • Bone pain
  • Bone sores (lesions)
  • Hormone (endocrine gland) problems
  • Fractures or bone deformities
  • Unusual skin color (pigmentation), which occurs with McCune-Albright syndrome

The bone lesions may stop when the child reaches puberty.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Fibrous Dysplasia?

There is no cure for fibrous dysplasia. Bone fractures or deformities are treated as needed. Hormone problems will need to be treated.

Who are the top Fibrous Dysplasia Local Doctors?
Roland D. Chapurlat
Elite in Fibrous Dysplasia
Elite in Fibrous Dysplasia

CHU Edouard Herriot

Lyon, FR 

Roland Chapurlat practices in Lyon, France. Mr. Chapurlat is rated as an Elite expert by MediFind in the treatment of Fibrous Dysplasia. His top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Fibrous Dysplasia, Osteitis Fibrosa, and Hip Replacement.

Elite in Fibrous Dysplasia
Elite in Fibrous Dysplasia
Leiden, ZH, NL 

Natasha Dijkstra-Appelman practices in Leiden, Netherlands. Ms. Dijkstra-Appelman is rated as an Elite expert by MediFind in the treatment of Fibrous Dysplasia. Her top areas of expertise are Fibrous Dysplasia, Mccune-Albright Syndrome, Osteitis Fibrosa, Parathyroidectomy, and Hormone Replacement Therapy (HRT).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Fibrous Dysplasia
Elite in Fibrous Dysplasia
Leiden, ZH, NL 

Bas Majoor practices in Leiden, Netherlands. Majoor is rated as an Elite expert by MediFind in the treatment of Fibrous Dysplasia. Their top areas of expertise are Fibrous Dysplasia, Osteitis Fibrosa, Mccune-Albright Syndrome, Precocious Puberty, and Bone Graft.

What is the outlook (prognosis) for Fibrous Dysplasia?

The outlook depends on the severity of the condition and the symptoms that occur.

What are the possible complications of Fibrous Dysplasia?

Depending on the bones that are affected, health problems that may result include:

  • If skull bone is affected, there can be vision or hearing loss
  • If a leg bone is affected, there can be difficulty walking and joint problems such as arthritis
When should I contact a medical professional for Fibrous Dysplasia?

Contact your provider if your child has symptoms of this condition, such as repeated bone fractures and unexplained bone deformity.

Specialists in orthopedics, endocrinology, and genetics may be involved in your child's diagnosis and care.

How do I prevent Fibrous Dysplasia?

There is no known way to prevent fibrous dysplasia. Treatment aims to prevent complications, such as recurrent bone fractures, to help make the condition less severe.

What are the latest Fibrous Dysplasia Clinical Trials?
Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome

Summary: Polyostotic fibrous dysplasia (PFD) is a sporadic disorder which affects multiple sites in the skeleton. The bone at these sites is rapidly resorbed and replaced by abnormal fibrous tissue or mechanically abnormal bone. PFD may occur alone or as part of the McCune-Albright Syndrome (MAS), a syndrome originally defined by the triad of PFD, cafe-au-lait pigmentation of the skin, and precocious puber...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry

Summary: The FD/MAS Patient Registry is an IRB-approved research study that that invites the patients and families to help answer some of the biggest questions about FD/MAS by completing questionnaires about their lives with FD or MAS. Have you enrolled in the FD/MAS Patient Registry yet? Are you up-to-date on your surveys? Take a trip to www.fdmasregistry.org today to learn more about the project, enroll,...

What are the Latest Advances for Fibrous Dysplasia?
Research progress in the pathogenesis and treatment of craniofacial fibrous dysplasia
Endoscopic optic nerve decompression for benign fibro-osseous lesions of the nasal and skull base
Tired of the same old research?
Check Latest Advances
Childhood fibrous dysplasia.
Who are the sources who wrote this article ?

Published Date: November 06, 2023
Published By: Neil K. Kaneshiro, MD, MHA, Clinical Professor of Pediatrics, University of Washington School of Medicine, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Nadol JB, Quesnel AM. Otologic manifestations of systemic disease. In: Flint PW, Francis HW, Haughey BH, et al, eds. Cummings Otolaryngology: Head and Neck Surgery. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 151.

Nicolai P, Mattavelli D, Castlenuovo P. Benign tumors of the sinonasal tract. In: Flint PW, Francis HW, Haughey BH, et al, eds. Cummings Otolaryngology: Head and Neck Surgery. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 50.

Shiflett JM, Caroll BW. Skull lesions in children. In: Winn HR, ed. Youmans and Winn Neurological Surgery. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 245.

Toy PC, Heck RK. Benign bone tumors and nonneoplastic conditions simulating bone tumors. In: Azar FM, Beaty JH, eds. Campbell's Operative Orthopaedics. 14th ed. Philadelphia, PA: Elsevier; 2021:chap 25.